In a report released today, Ryan Zimmerman from BTIG reiterated a Buy rating on Globus Medical (GMED – Research Report), with a price target of ...

JPMorgan keeps an Overweight rating on Boston Scientific (BSX) with a $110 price target after the company announced an agreement to acquire the ...

We recently published a list of 10 Firms Post Strong Gains Amid Wall Street Bloodbath. In this article, we are going to take ...

On Tuesday, BioNano Genomics Inc (BNGO) stock saw a decline, ending the day at $0.27 which represents a decrease of $-0.01 or -3.57% from the prior close of $0.28. The stock opened at $0.28 and ...

Energy is the star sector of the S&P 500 index in the early days of 2025, shaking off two consecutive years when it was a market laggard, and gaining despite Wall Street’s dim outlook for oil and gas ...

Boot Barn Holdings Inc operates specialty retail stores. The company sells western and work-related footwear, apparel, and ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $2308.0, ...

BTIG Research has recently reduced Beyond Air Inc (XAIR) stock to Neutral rating, as announced on June 25, 2024, according to Finviz. Earlier, on July 28, 2023, Piper Sandler had initiated the stock ...

US stock futures steadied Wednesday, with investors cautious ahead of the release of more employment data as well as the ...

BTIG analyst Thomas Shrader lowered the firm’s price target on Denali Therapeutics (DNLI) to $32 from $35 and keeps a Buy rating on the shares after the company announced topline data from the Phase 2 ...

Palo Alto Networks (PANW – Research Report) received a Hold rating and price target from BTIG analyst Gray Powell today. The company’s shares ...

Truist Financial started coverage on shares of Synchrony Financial (NYSE:SYF – Free Report) in a report issued on Tuesday ...